NCT02079922
- Conditions
- Dyslipidemias, Healthy, Hypercholesterolemia, +4 more
- Locations
-
- Pfizer Investigational Site Brussels, Belgium
Clinical trial condition
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
NCT02079922
NCT01992614
NCT01311375
NCT00813527
NCT01365078
NCT01279590
NCT01224561
NCT00701727
NCT00841217
NCT00632840
Not specified